Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9101637 | PLX PHARMA | Methods of treating inflammation with compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
Mar, 2022
(1 year, 6 months ago) | |
US8865187 | PLX PHARMA | Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
Mar, 2022
(1 year, 6 months ago) | |
US10786444 | PLX PHARMA | PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same |
Sep, 2032
(9 years from now) | |
US10646431 | PLX PHARMA | PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same |
Sep, 2032
(9 years from now) | |
US9226892 | PLX PHARMA | pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same |
Sep, 2032
(9 years from now) | |
US9216150 | PLX PHARMA | pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same |
Sep, 2032
(9 years from now) |
Drugs and Companies using ASPIRIN ingredient
Market Authorisation Date: 14 January, 2013
Treatment: Treatment/prevention of cardiovascular disease; Temporary reduction of fever; Temporary relief of minor aches and pains; A method of targeting release of a non-steroidal anti-inflammatory drug (nsaid)...
Dosage: CAPSULE;ORAL
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic